Latest Anemia News
Pre-Dialysis Anemia Ups Mortality After Dialysis Start
Patients with vs without anemia prior to starting hemodialysis (HD) were more likely to die despite achieving target hemoglobin levels at month 4 after HD initiation.
Reducing PTH Might Improve Anemia in Hemodialysis
Anemia control may be one more reason to treat elevated parathyroid hormone levels.
FGF23 Predicts Development of CKD Anemia
Anemia is 66% and 84% more likely to develop among patients in the 3rd and 4th quartiles of serum fibroblast growth factor 23 level vs those in the 1st quartile.
FDA Approves 'Biosimilar' Drug to Treat Certain Types of Anemia
Retacrit is biosimilar to the drugs Epogen and Procrit.
Change in Red Blood Cell Distribution Width Tied With Mortality in HD
In a study, increases in red blood cell distribution width during the first year of dialysis was associated with greater risks for death.
Vadadustat Maintains Hemoglobin Levels in Hemodialysis Patients
Patients' mean hemoglobin levels stayed relatively stable after converting from an erythropoiesis-stimulating agent to the investigational drug.
No Reduction in Platelets Found With IV Iron Use in CKD
New study shows that IV iron repletion with sodium ferric gluconate complex increased platelet count significantly at week 3 post-infusion and non-significantly at week 4.
FDA Updates Triferic Label With New Safety Warning
Clinicians should advise women who could become pregnant to use effective contraception before and after taking the anemia drug.
Anticoagulation Therapy May Prevent CV Events, Worsen Anemia in CKD
In a study, use of anticoagulants was associated with 85% fewer atherosclerotic events.
Calcitriol Found Not to Improve Hepcidin Levels in CKD
In a trial, oral calcitriol of 0.5 mcg daily did not reduce hepcidin levels in patients with stage 3 to 4 CKD.
Higher-Dose IV Iron Appears Safe in Dialysis
Dialysis patients receiving more or less than 200 mg per month of IV iron had similar risks of death, infection, cardiovascular disease, and hospitalization, meta-analysis shows.
FDA Broadens Feraheme Use for Iron Deficiency Anemia
The Food and Drug Administration broadened the existing labeling for Feraheme (ferumoxytol injection) beyond the current chronic kidney disease indication.
Most CKD Patients With Anemia Show Limited Response to Oral Iron
In a 52-week trial, more than half of nondialysis-dependent chronic kidney disease patients with anemia treated with oral iron had no rise in their hemoglobin levels.
Anemia in Dialysis Patients Linked With Hemorrhagic Stroke
Patients with hemoglobin values of 9.7 g/dL or below had more than double the risk for hemorrhagic stroke compared with patients with hemoglobin values of 11.2 g/dL or above.
CERA Effective for Pediatric Hemodialysis Patients With Anemia
The safety profile of CERA is similar for children as for adults.